Category: St. Jude MedicalSyndicate content

St. Jude's Nanostim pacemaker looks good at 3 months in feasibility study

March 25, 2014 by Brad Perriello

A small European feasibility study of the Nanostim leadless pacemaker acquired by St. Jude Medical looks good at 3 months, according to a study published in the American Heart Assn. journal Circulation.

St. Jude's Nanostim pacemaker looks good at 3 months in feasibility study

The Nanostim leadless pacemaker acquired by St. Jude Medical (NYSE:STJ) last year appeared safe and functional after 3 months, according to results of a small study published in the American Heart Assn. journal Circulation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AIM: Medtronic, St. Jude recalls illustrate why PMA modifications don't work

March 24, 2014 by Arezu Sarvestani

A new editorial in the Annals of Internal Medicine criticizes the premarket approval modification process, through which both Medtronic and St. Jude Medical released high-risk products that were later recalled.

AIM: Medtronic, St. Jude recalls illustrate why PMA modifications don't work

St. Jude Medical's Allure Quadra pacemaker wins FDA OK

March 24, 2014 by Brad Perriello

The FDA grants pre-market approval to St. Jude Medical's Allure Quadra cardiac resynchronization therapy pacemaker.

St. Jude Medical's Allure Quadra pacemaker wins FDA OK

St. Jude Medical (NYSE:STJ) said its Allure Quadra pacemaker will be the 1st on the U.S. market to offer quadripolar cardiac resynchronization therapy after the FDA granted pre-market approval to the device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude's Prodigy chronic pain neurostim device lands CE Mark

March 20, 2014 by Brad Perriello

St. Jude Medical says its Prodigy neurostimulation device won CE Mark approval in the European Union for a chronic pain indication.

St. Jude's Prodigy chronic pain Nuristan device lands CE Mark

St. Jude Medical (NYSE:STJ) said it's putting its Prodigy neurostimulation device on the market in Europe for patients with chronic back pain after winning CE Mark approval.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Volcano appeals loss to St. Jude Medical in FFR war

March 19, 2014 by Brad Perriello

Volcano appeals a Delaware federal judge's dismissal of its lawsuit against St. Jude Medical over fractional flow reserve patents.

Volcano appeals loss to St. Jude Medical in FFR war
Volcano appeals loss to St. Jude Medical in FFR war

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical launches post-approval Nanostim trial in Europe

March 18, 2014 by Brad Perriello

St. Jude Medical says it's launched a post-approval study in Europe for its Nanostim leadless pacemaker and performed the 1st implantations in a U.S. pivotal trial.

St. Jude Medical launches post-approval Nanostim trial in Europe

St. Jude Medical (NYSE:STJ) said it's enrolled the 1st patients in a post-approval trial of the Nanostim leadless pacemaker it acquired in October 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp